239 related articles for article (PubMed ID: 1637131)
1. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.
Arnold DL; Matthews PM; Francis GS; O'Connor J; Antel JP
Ann Neurol; 1992 Mar; 31(3):235-41. PubMed ID: 1637131
[TBL] [Abstract][Full Text] [Related]
2. Chemical pathology of acute demyelinating lesions and its correlation with disability.
De Stefano N; Matthews PM; Antel JP; Preul M; Francis G; Arnold DL
Ann Neurol; 1995 Dec; 38(6):901-9. PubMed ID: 8526462
[TBL] [Abstract][Full Text] [Related]
3. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.
Narayana PA; Doyle TJ; Lai D; Wolinsky JS
Ann Neurol; 1998 Jan; 43(1):56-71. PubMed ID: 9450769
[TBL] [Abstract][Full Text] [Related]
4. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
[TBL] [Abstract][Full Text] [Related]
5. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
6. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.
Arnold DL; Riess GT; Matthews PM; Francis GS; Collins DL; Wolfson C; Antel JP
Ann Neurol; 1994 Jul; 36(1):76-82. PubMed ID: 8024266
[TBL] [Abstract][Full Text] [Related]
7. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
8. Correlations of evoked potentials with MR imaging and MR spectroscopy in multiple sclerosis.
Kraft GH; Richards TL; Heide AC
Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):561-7, vi. PubMed ID: 9894109
[TBL] [Abstract][Full Text] [Related]
9. Cerebral metabolites in patients with acute and subacute strokes: concentrations determined by quantitative proton MR spectroscopy.
Mathews VP; Barker PB; Blackband SJ; Chatham JC; Bryan RN
AJR Am J Roentgenol; 1995 Sep; 165(3):633-8. PubMed ID: 7645484
[TBL] [Abstract][Full Text] [Related]
10. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H
Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178
[TBL] [Abstract][Full Text] [Related]
11. Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type 1.
Mascalchi M; Tosetti M; Plasmati R; Bianchi MC; Tessa C; Salvi F; Frontali M; Valzania F; Bartolozzi C; Tassinari CA
Ann Neurol; 1998 Feb; 43(2):244-52. PubMed ID: 9485066
[TBL] [Abstract][Full Text] [Related]
12. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions.
Narayanan S; Fu L; Pioro E; De Stefano N; Collins DL; Francis GS; Antel JP; Matthews PM; Arnold DL
Ann Neurol; 1997 Mar; 41(3):385-91. PubMed ID: 9066360
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopic imaging in patients with cerebellar degeneration.
Tedeschi G; Bertolino A; Massaquoi SG; Campbell G; Patronas NJ; Bonavita S; Barnett AS; Alger JR; Hallett M
Ann Neurol; 1996 Jan; 39(1):71-8. PubMed ID: 8572670
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV
Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance spectroscopy predicts outcomes for children with nonaccidental trauma.
Aaen GS; Holshouser BA; Sheridan C; Colbert C; McKenney M; Kido D; Ashwal S
Pediatrics; 2010 Feb; 125(2):295-303. PubMed ID: 20123781
[TBL] [Abstract][Full Text] [Related]
17. Traumatic brain injury and subarachnoid hemorrhage: in vivo occult pathology demonstrated by magnetic resonance spectroscopy may not be "ischaemic". A primary study and review of the literature.
Macmillan CS; Wild JM; Wardlaw JM; Andrews PJ; Marshall I; Easton VJ
Acta Neurochir (Wien); 2002 Sep; 144(9):853-62; discussion 862. PubMed ID: 12376766
[TBL] [Abstract][Full Text] [Related]
18. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
Pascual AM; Martínez-Bisbal MC; Boscá I; Valero C; Coret F; Martínez-Granados B; Marti-Bonmati L; Mir A; Celda B; Casanova B
Neurology; 2007 Jul; 69(1):63-7. PubMed ID: 17606882
[TBL] [Abstract][Full Text] [Related]
19. High spatial resolution MRI and proton MRS of human frontal cortex.
López-Villegas D; Kimura H; Tunlayadechanont S; Lenkinski RE
NMR Biomed; 1996 Oct; 9(7):297-304. PubMed ID: 9134540
[TBL] [Abstract][Full Text] [Related]
20. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus.
Brooks WM; Sabet A; Sibbitt WL; Barker PB; van Zijl PC; Duyn JH; Moonen CT
J Rheumatol; 1997 Dec; 24(12):2323-9. PubMed ID: 9415636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
